The influence of the drug LHS-1208 on cardiovascular system

Introduction.This article presents a fragment of a preclinical toxicological study of a new Russian anticancer drug derived from n-glycoside indolokarbazole LCS-1208 – study of cardiotoxicity, which is one of the specific complications of anticancer chemotherapy.

Objective.Preclinical toxicological study of the effect of the drug LCS-1208 on the cardiovascular system of animals to assess its cardiotoxic effects.

Materials and methods.Studies were conducted on 40 healthy non-harmless mongrel male rats and 4 dogs Beagle, male and female. The drug was administered daily 15 times to rats-intraperitoneal in total doses of 50, 100 and 200 mg/kg; to dogs – intravenously in total doses of 20 and 30 mg/kg. The period of observation of rats was 30 days, for dogs was 60 days. Changes in electrocardiogram indices, macroscopic and histological picture of heart changes and changes in biochemical parameters of enzymes activity – lactate dehydrogenase and aspartate aminotransferase were evaluated.

Results.In rats LCS-1208 throughout the period of observation caused functional changes in electrocardiogram: increase in PQ and QT intervals and cardiac rhythm disturbance (loss of R wave), which indicates a violation of electrical conductivity. Morphological changes in the heart muscle were detected on the 3rd day of observation in total doses of 100 and 200 mg/kg, which remained until 30 days of observation only in animals receiving the drug in the total dose of 200 mg/kg. In some dogs for different periods of observation the drug caused functional changes in the electrical activity of the heart: an increase in the QRS interval, the inversion of the T wave, the appearance of a deep Q wave and an increase in the activity of lactate dehydrogenase and aspartate aminotransferase compared to back ground indicators. Morphological changes in the heart muscle were detected on the 3rd day of observation only in the total dose of 30 mg/kg, which persisted up to 60 days of observation.

Conclusion.It was found that the new Russian anticancer drug LHC-1208, a derivative of indocarbazole N-glycoside, has a cardiotoxic effect, causing functional changes in the cardiovascular system of rats in all doses studied, and in dogs only in the maximum dose. Morphologically, cardiotoxicity is not confirmed in animals receiving a minimal dose of the drug, but only in animals receiving the maximum dose of the drug.

1. Gershanovich L.L. Complications of chemotherapy and hormone therapy of malignant tumors. Moscow: Meditsina, 1982. Pp. 89–97 (In Russ.)

2. Guide to chemotherapy of tumor diseases. Ed.N.I. Perevodchikova 3rd ed., updated and revised. Moscow: PrakticheskayaMeditsina, 2011. Pp. 435–436 (In Russ.)

3. Encyclopedia of Clinical Oncology: A Handbook for Practitioners. M.I. Davydov, G.L. Vyshkovsky et al.; Eds.M. I. Davydov, G.L. Vyshkovsky. Moscow: RLS-2005, 2004. 1427 p. (In Russ.)

4. TikhonovaN.I., YartsevaI.V., EreminaV.A. etal. N-glycosides indolo[2,3-a]pyrrolo[3,4-c]carbazoles with antitumor activity/and others; the applicant and the patent holder Patent No. 2548045 Russian Federation, IPC C07N 19/04, A61R 35/00, A61K 31/7008. Publ. 10.04.15, Bul. № 10. 13 p. (In Russ.)

5. Goryunova O.V., Appleshko G.N., Pugacheva R.B. et al. Study of the antitumor activity of amino acid derivatives of indolo[2,3a]carbazoles. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2015;14(1):74 (In Russ.)

6. YavorskayaN.P., GolubevaI.S., EreminV.A. etal. Study of the antitumor activity of indolo[2,3a]carbazoles. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2015;14(1):149 (In Russ.)

7. Kiseleva M.P., Borisova L.M., Ektova L.V. et al. Investigation of the antitumor activity of new compounds in a series of glycoside derivatives of indolocarbazoles. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2018;17(1S):35 (In Russ.)

8. Golubeva I.S., Yavorskaya N.P., Eremina V.A. et al. Antitumor activity of glycosides of indolocarbazoles. Rossiysky Bioterapevtichesky Zhurnal =Russian Journal of Biotherapy 2016;15(1S):23–4 (In Russ.)

9. Yartseva I.V., Ignatieva E.V., Dmitricheva N.A. et al. Standardization of LHS-1208. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2016;15(1):126–7 (In Russ.)

10. Lantsova A.V., Sanarova E.V., Oborotova N.A. et al. Development of the technology for the preparation of an injectable dosage form based on the domestic substance of an indolocarbazole derivative – LHS-1208. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2014;12(3):25–32 (In Russ.)

11. Kiseleva M.P., Shprakh Z.S., Borisova L.M. et al. Preclinical studyof the antitumor activity of the derivativeof N-glycoside indolocarbazoleLHS-1208. Message I. RossiyskyBioterapevtichesky Zhurnal = RussianJournal of Biotherapy 2015;14(2):71–7 (In Russ.)

12. Kiseleva M.P., Shprakh Z.S., Borisova L.M. et al. Preclinical study of the antitumor activity of the derivative of N-glycoside indolocarbazole LHS-1208. Communication II. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2015;14(3):41–7 (In Russ.)

13. Kiseleva M.P., Shprakh Z.S., Dezhenkova L.G. et al. The effect of the derivative of indolocarbazoles LHS-1208 on topoisomerase I. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2015;14(1):89 (In Russ.)

14. KiselevaM.P., BorisovaL.M., ShprakhZ.S. etal. Antimetastatic action of the derivative of indolocarbazoles LHS-1208. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2015;14(1):90 (In Russ.)

15. SmirnovaZ.S., BorisovaL.M., KiselevaM.P. etal. Preclinical study of the antitumor activity of the derivative of indolocarbazole LHS-1208. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2014;13(1):129 (In Russ.)

16. Vartanyan A.A., Baryshnikova M.A., Burova O.S. et al. The blocker of vasculogenic mimicry restores the sensitivity of resistant melanoma cells to DNA alkylating agents. Vestnik RONC im. N.N. Blokhina = Journal of N.N. Blokhin Russian cancer research center 2016;27(2):164–71 (In Russ.)

17. Nikolina A.A., Kulbachevskaya N.Yu., Konyaeva O.I. et al. The study of the “acuteˮ toxicity of a new antitumor drug – based on the derivative of indolocarbazole LHC-1208. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2015;14(4):59–64 (In Russ.)

18. Nikolina A.A., Kulbachevskaya N.Yu., Konyaeva O.I. et al. A study of the subchronic toxicity of a new antitumor drug, a glycoside derivative of indolocarbazole LHS-1208 in rats. Russian Biotherapeutic Journal 2016;15(3):62–9 (In Russ.)

19. Nikolina A.A. Kulbachevskaya N.Yu., Konyaeva O.I. et al. A preclinical study of the toxicity of a new antitumor drug, the glycoside derivative of indocarbazole LHS-1208, has been made. Uspekhi molekulyarnoy onkologii = The successes of molecular oncology 2016;3(3):88 (In Russ.)

20. Ermakova N.P., Kulbachevskaya N.Yu., Merkulova I.B. et al. The influence of LHS-1208 on the cardiovascular system of rats. Theses of the Sechenov International Summit 2017:59–60 (In Russ.)

21. Kulbachevskaya N.Yu., Konyaeva O.I., Ermakova N.P. et al. “Subchronic” toxicity of a drug based on an indolocarbazole derivative in rats. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2015;14(1):99 (In Russ.)

22. Kulbachevskaya N.Yu., Konyaeva OI, Ermakova N.P. et al. “Acute” toxicity of a drug based on an indolocarbazole derivative (LHS-1208) on small laboratory animals. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2015;14(1):100 (In Russ.)

23. Nikolina A.A., Kulbachevskaya N.Yu., Konyaeva O.I. et al. Subchronic toxicity of the drug based on the glycoside derivative of indolocarbazole on dogs. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2016;15(1):77 (In Russ.)

24. Principles of Good Laboratory Practice. National Standard of the Russian Federation (GOST 53434–2009). Moscow: Standartinform, 2010. (InRuss.)

25. On approval of the Rules of Laboratory Practice. Order of the Ministry of Health and Social Development of the Russian Federation(Ministry of Health and Social Development of Russia) from 01 April 2016 No. 199n (In Russ.)

26. Bolshakov O.P., Neznanov N.G., Babakhanyan R.V. Didactic and ethical aspects of research on biomodels and laboratory animals. Kachestvennaya klinicheskaya praktika = Qualitative clinical practice 2002:1–53 (In Russ.)

27. Methodical instructions for studying the general toxic effects of drugs. In: Handbook on preclinical drug research. General ed. by Ph.D. A. N. Mironov. Moscow: Grif i K, 2012. 944 p. (In Russ.)

28. Mikhailova L.M., Syrkin A.B., Garin A.M. et al. Methodical instructions for studying the general toxic effect of antitumor pharmacological agents. In: Guide to experimental (preclinical) study of new pharmacological substances. Gen. ed. by Corresponding Member of the Russian Academy of Medical Sciences prof. R.U. Khabriev. 2nd ed., updated and revised. Мoscow: Meditsina, 2005.832 p. Pp. 170–204 (InRuss.)

29. llarionova V. K., Ippolitova T.V.,Denisenko V.N. Fundamentalsof electrocardiography in dogs. Tutorial.Moscow: K.I. Skryabin Moscow StateAcademy of Veterinary Medicine andBiotechnology, 2004 (In Russ.)

30. Murashko V.V., Strutynskiy A.V. Electrocardiography: a textbook. 3rd ed., updated and revised. Moscow: MEDPress-inform 1999 (InRuss.)

31. Nimand H.N., Suter P.F. Diseases of dogs. Practical guidance of veterinarians. Moscow: Aquarium, 1998 (InRuss.)

32. Volkova O.V., Eletskiy Yu.K. Fundamentals of histology with histological technique. 2nd ed., updated and revised. Moscow: Meditsina, 1982 (InRuss.)

33. Gritsevskaya I.L. Changes in the myocardium of white rats under the influence of the pesticide “Croneton”. In: Morphological methods of research in hygiene and toxicology. Coll. of Scientific Works.Moscow: Meditsina, 1983. Pp. 11–14 (In Russ.)